AstraZeneca Unloads Four NDAs to ANI Pharmaceuticals in $46.5M Deal Post author:Sam Post published:December 28, 2017 Post category:BioPharma ANI Phamaceuticals funded the acquisitions through a combination of cash and debt. Source: BioSpace You Might Also Like <b>SGI-DNA</b> Launches Automated Next-Generation Sequencing Library Construction Kits For The BioXp 3200 System To Expand The Capabilities Of The Genomic Workstation March 28, 2017 Mettler-Toledo To Exhibit At Annual Conference In Fort Worth, TX October 8, 2017 Bayer HealthCare Expansion Brings New Jobs to the Bay Area August 16, 2017
<b>SGI-DNA</b> Launches Automated Next-Generation Sequencing Library Construction Kits For The BioXp 3200 System To Expand The Capabilities Of The Genomic Workstation March 28, 2017
